Bezlotoxumab

Records for this ingredient, by country (identity only).

ATC J06BC03 · 6 markets · 6 records

Bezlotoxumab 6 markets · 6 records Forms
Filters
MarketUS 1GB 1CN 1

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 25 mg per mL / per unit basis not statedinjectionZINPLAVA

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 1,000 mg/40 mLinjectionZinplava 1g/40ml concentrate for solution for infusion vials

CN 1 records · 1 shown of 1 Source 国家医保局 医保药品分类与代码数据库 · Data as of 2025-04-04

  • 10 mg per mL / per unit basis not statedinjection新替妥贝洛托舒单抗

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.